Comprehensive Review of Weight Management in People With HIV
You must Login or Create Account in order to register for this event
Presenter
Moderator
January 23, 2025
10:30 AM – 11:45 AM PTOverview
Assessment of Needs
Weight gain is a common side effect of antiretroviral therapy (ART). This webinar will discuss contributors to weight gain in patients on ART and review current treatment options to manage weight gain in patients with HIV.
Learning Objectives
On completion of this activity, learners will be able to:
- Identify contributors to weight gain in patients on antiretroviral therapy
- Understand available treatment options for management of weight gain
- Implement GLP-1 receptor agonists (GLP-1RAs) as a novel therapeutic class for weight loss
- Summarize recent studies of GLP-1RA use among people with HIV and describe potential clinical challenges with GLP-1RA use
Registration
Who Should Attend
This webinar is designed for clinical decision makers who are actively involved in HIV care and research, including physicians, physician assistants, nursing professionals, pharmacists, and other health care professionals.
Individual registration is required in order to receive CME credit or a certificate of participation.
Registration closes on Thursday, January 23, 2025, 11:00 AM (PT).
For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.
Conflicts of Interest
In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.
The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”
IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.
Presenter
Dr Rajagopal reported no relevant financial relationships with ineligible companies (Updated July 26, 2024)
Moderator
Dr Bedimo reported receiving research grants awarded to his institution from Merck & Co, Inc, and serving on the scientific advisory board for Merck & Co, Inc, ViiV Healthcare, Gilead Sciences, Inc, Shionogi, and Janssen Pharmaceuticals. (Updated February 12, 2024)
Planner/Reviewer
Planner/Reviewer 2 reported no relevant financial relationships with ineligible companies (Updated July 29, 2024)
COW Board
The financial relationships of the COW Board can be found here: https://www.iasusa.org/activities/cases-on-the-web/about-cows/cow-webinars-editorial-board/
CME Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits.
Nursing Credits
This activity is eligible for ANCC credit, see final CNE activity announcement for specific details.
Pharmacy Credits
This activity is eligible for ACPE credit, see final CPE activity announcement for specific details
Grant Support
IAS–USA funding comes from a variety of sources. The largest single source of revenue is CME participant registration fees. Other funding sources include grants from ineligible companies (previously defined as “commercial interests”) and diagnostics industries, private donations, and gifts-in-kind from local community businesses and individuals. Support from ineligible companies will be announced as it becomes available.
Frequently Asked Questions
View our list of FAQs about attending a webinar.
Further Questions?
Please contact the registration department at registration@iasusa.org or 415-544-9400.